No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹2,116Prev. Close
₹2,103.2Turnover(Lac.)
₹7,584.23Day's High
₹2,131.9Day's Low
₹2,088.152 Week's High
₹3,50052 Week's Low
₹2,096Book Value
₹132.3Face Value
₹10Mkt Cap (₹ Cr.)
35,939.49P/E
39.57EPS
53.59Divi. Yield
2.6913 May 2025
12:00 AM
AGM
Announcement Date: 13 May, 2025
22 Apr 2026
12:00 AM
Board Meeting
Agenda : Audited Result
13 May 2026
12:00 AM
Dividend
Dividend Amount: 57
Record Date: 29 May, 2026
At around 2.14 PM, GSK Pharma was trading 0.28% higher at ₹2,806.70 per piece, against the previous close of ₹2,798.80 on NSE.
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 169.41 | 169.41 | 169.41 | 169.41 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,071.77 | 1,779.82 | 1,614.69 | 1,583.59 |
Net Worth | 2,241.18 | 1,949.23 | 1,784.1 | 1,753 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 3,217.5 | 2,920.47 | 3,224.68 | 2,871.68 |
yoy growth (%) | 10.17 | -9.43 | 12.29 | -1.07 |
Raw materials | -1,295.73 | -1,249.36 | -1,307.86 | -1,240.75 |
As % of sales | 40.27 | 42.77 | 40.55 | 43.2 |
Employee costs | -610.23 | -616.16 | -628.55 | -523.39 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 761.86 | 625.82 | 646.99 | 523.78 |
Depreciation | -68.18 | -78.6 | -82.67 | -37.98 |
Tax paid | -396.86 | -166.53 | -212.44 | -189.59 |
Working capital | 776.94 | 111.42 | 187.45 | -365.58 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 10.17 | -9.43 | 12.29 | -1.07 |
Op profit growth | 26.44 | -9.21 | 29.5 | 21.07 |
EBIT growth | 21.37 | -3.66 | 24.68 | 12.53 |
Net profit growth | 372.78 | 224.9 | -68.73 | 4.51 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 3,821.67 | 3,749.21 | 3,453.71 | 3,251.72 | 3,278.03 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,821.67 | 3,749.21 | 3,453.71 | 3,251.72 | 3,278.03 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 165.98 | 150.62 | 122.59 | 103.71 | 1,401.31 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,807.7 | 144.46 | 4,33,619.81 | 608.7 | 0.89 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,638 | 66.14 | 1,76,086.64 | 756 | 0.45 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,571.2 | 69.99 | 1,54,837.1 | 467 | 0.83 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,389.4 | 32.59 | 1,12,193.56 | 384.64 | 0.94 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,104.7 | 30.09 | 1,11,123.45 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Renu S. Karnad
Managing Director
Bhushan Akshikar
Non Executive Director
Subesh Williams
Independent Non Exe. Director
Manu Anand
Independent Non Exe. Director
Sunita Maheshwari
Independent Non Exe. Director
Somasundaram Palamadairamaswamy
Independent Non Exe. Director
Anup Wadhawan
Whole Time Director & CFO
Ronojit Biswas
VP / Company Secretary / Compliance Officer
A A Nadkarni
GSK House,
Dr Annie Besant Road Worli,
Maharashtra - 400030
Tel: 91-022-24959595
Website: http://www.gsk-india.com
Email: askus@gsk.com; ajay.a.nadkarni@gsk.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@karvy.com
Summary
GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as Glindia Limited in November, 1924. The Company s name was changed to Glaxo (India) Limited in 1987 and was again changed to GlaxoS...
Read More
Reports by Glaxosmithkline Pharmaceuticals Ltd
What is the Glaxosmithkline Pharmaceuticals Ltd share price today?
What is the Market Cap of Glaxosmithkline Pharmaceuticals Ltd?
What is the PE and PB ratio of Glaxosmithkline Pharmaceuticals Ltd?
What is the 52 Week High and Low of Glaxosmithkline Pharmaceuticals Ltd?
What is the CAGR of Glaxosmithkline Pharmaceuticals Ltd?
What is the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
